Nurix Therapeutics (NRIX) Net Income Growth (5y) (2024 - 2026)

Nurix Therapeutics (NRIX) Net Income Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn -
4 BeOne Medicines 469.79 Bn 465.00 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn
7 Belite Bio 62.62 Bn 62.62 Bn -
8 Argenx Se 56.18 Bn 50.99 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Nurix Therapeutics 2.61 Bn 2.17 Bn -

Historic Data

Download Data
DateValue
May 31, 2026 -27.72%
Feb 28, 2026 -29.36%
Nov 30, 2025 -31.44%
Aug 31, 2025 -36.08%
May 31, 2025 -50.55%
Feb 28, 2025 -35.38%
Nov 30, 2024 -34.14%
Aug 31, 2024 -82.37%